Skip to main content

SIG BROKERAGE, LP

Broker-Dealer

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1094429 BALA CYNWYD, PA

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,121,784
+$3,260,448 QoQ
Shares Held
22,390
+27.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
2.01%
of 13F equity value
Holder Rank
#350
of 1,745 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Derivatives in VRTX

reported options exposure · as of Dec 31, 2025
CallValue
$906,720
CallShares
2,000
PutValue
$4,306,920
PutShares
9,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SIG BROKERAGE, LP holds $14,503,065 across 7 Biotechnology names. VRTX ranks #1 (76.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
22,390 $11,121,784

All Filings in VRTX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,121,784 22,390
2026-03-31 $7,861,336 17,605
2025-12-31 $906,720 2,000
2025-12-31 $9,458,903 20,864
2025-12-31 $4,306,920 9,500
2025-09-30 $1,566,560 4,000
2025-09-30 $5,913,764 15,100
2025-09-30 $10,335,379 26,390
2025-06-30 $3,339,000 7,500
2025-06-30 $14,498,383 32,566
2025-03-31 $4,848,200 10,000
2025-03-31 $542,998 1,120
2025-03-31 $3,636,150 7,500
2024-12-31 $780,432 1,938
2024-12-31 $3,020,250 7,500